EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners
22.4.2020 09:00:00 EEST | Business Wire | Press release
EnginZyme, the cell-free synthetic biology company, today announced a Series A investment of €6.4 million led by Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, bringing the company’s total funding to over €10 million since 2014.
The funds will be used to accelerate the development of EnginZyme’s technology platform and take its first internal production process to pilot. The company also announced that Michael Krel, Partner of the Sofinnova Industrial Biotech Fund, will join EnginZyme’s Board of Directors.
“Sofinnova Partners brings a deep industrial experience, which makes them the perfect partner for us,” said EnginZyme CEO Dr. Karim Engelmark Cassimjee. “This is a complex field, so it is important to have investors that can provide not only the financial support but also strategic guidance. With over a decade of experience investing in industrial biotechnology, there are few investors as well placed as Sofinnova Partners to bring this domain expertise to the table.”
“There's never been a more important time to provide solid, long-term support to pioneering companies in industrial biotechnology,” said Michael Krel, Partner of the Sofinnova Industrial Biotech Fund. “We strongly believe in EnginZyme’s outstanding team and the potential of its technology to join the power of biology with the efficiency of chemical engineering to bring us towards a more sustainable future.”
EnginZyme seeks to solve one of the fundamental problems of our time: How to produce sustainable alternatives to plastics, nylons, rubbers, and the tons of other synthetics that are used on a daily basis, without compromising on cost-effectiveness. To achieve this, EnginZyme’s technology platform combines the breadth and power of nature (enzymatic cascades) with the efficiency of the chemical industry (packed bed reactors) in a best-of-both-worlds technical solution.
“It has long been recognized that if we could effectively access nature’s full palette of molecules, we could solve many of the world’s most pressing problems,” said Dr. Engelmark Cassimjee. “There’s just so much more you can do with biological systems than with traditional catalysts and petroleum-based building blocks. But the key word here is ‘effectively’ — it needs to be as cheap and easy to scale as the chemical solutions we’ve used for more than a century now. We’re the first company to truly address that and by doing so we are building foundational technology for an entire future industry.”
About EnginZyme
EnginZyme’s cell-free synthetic biology platform marries the efficiency of the chemical industry with the power and diversity of biology. The company was founded in Stockholm, Sweden. Since its start in 2014 it has used its technology to provide R&D services to leading companies in multiple industries, such as pharma, food, chemicals and flavors & fragrances. Its long-term aim is to make its cell-free synbio platform the foundation upon which the future chemical industry rests.
For more information, please visit: www.enginzyme.com
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, with offices in London and Milan, the firm brings together a team of 40 professionals from all over Europe, the U.S. and Asia. The firm focuses on paradigm-shifting technologies alongside visionary entrepreneurs. Sofinnova Partners invests across the Life Sciences value chain as a lead or cornerstone investor, from very early-stage opportunities to late-stage/public companies. It has backed nearly 500 companies over more than 48 years, creating market leaders around the globe. Today, Sofinnova Partners has over €2 billion under management.
For more information, please visit: www.sofinnovapartners.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200421005045/en/
Contact information
Beatrix Ellis
press@enginzyme.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Silo Communications expands fiber connectivity in rural Illinois with Adtran16.7.2026 15:00:00 EEST | Press release
Adtran today announced that Silo Communications, a rural broadband provider based in northern Illinois, is using its fiber access portfolio and software applications to expand high-speed connectivity for underserved homes and businesses. As demand for reliable broadband continues to grow across communities, Silo Communications is building on its wireless heritage with a scalable fiber network designed to support higher speeds, stronger service reliability and future expansion. The deployment supports wider state and federal efforts to extend high-speed connectivity to underserved rural areas, strengthening Silo Communications’ ability to connect residents, local enterprises and agricultural businesses that have historically had limited access to high-performance broadband. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716640241/en/ Adtran’s fiber access technology is helping Silo Communications deliver high-speed connect
Elliptic Launches Next-Generation Continuous Monitoring, Giving Crypto Compliance Teams a Live View of Customer Risk Without the Flood of Alerts16.7.2026 15:00:00 EEST | Press release
Elliptic, the global leader in digital asset decisioning, today launched the next generation of Continuous Monitoring, a solution that gives crypto compliance teams a continuously accurate view of customer risk rather than a picture frozen at the last screening. Elliptic's Continuous Monitoring is the most comprehensive risk monitoring solution on the market, and the only one to pair the industry's broadest event detection with fully configurable alerting. It is available to compliance teams today. "Monitoring obligations on MLROs are getting more stringent, putting both their companies and, sometimes, themselves at risk. Existing monitoring solutions fail twice over: They leave exposure gaps by only alerting on obvious triggers like label changes while missing the rest. On the exposure they do catch, they fire so indiscriminately that teams drown in alerts that don’t matter. We’ve built Continuous Monitoring to cover the full range of events that change a customer's risk, and to alert
MultiBank Group Named Forex Broker of the Year 2026 at Money Expo Abu Dhabi16.7.2026 14:35:00 EEST | Press release
MultiBank Group, one of the world's largest and most regulated online financial derivatives institutions, has been named Forex Broker of the Year at Money Expo Abu Dhabi. The event was held on 8–9 July 2026 at the ADNEC Centre. This flagship award recognizes the broker setting the benchmark for excellence across the global trading and fintech industry. MultiBank Group's participation in the expo underscored its leadership position within the Middle East's financial landscape. A Landmark Event for Trading and Fintech Money Expo Abu Dhabi 2026 brought together traders, banks, fintech firms, liquidity providers, and market leaders from across the region and beyond. Winning top honors on this stage sends a clear signal across the entire industry. “Being named Forex Broker of the Year is a defining moment for our Group,” said Johny Giacaman, Chief Business Operations Officer at MultiBank Group. “It reflects two decades of regulatory discipline, technological innovation, and an unwavering co
illumynt Appoints Anthony Giannetti as Senior Vice President of Global Operations16.7.2026 14:00:00 EEST | Press release
illumynt, a technology-driven leader in AI hardware lifecycle recovery and IT asset disposition (ITAD), today announced that Anthony "Tony" Giannetti has joined the company as Senior Vice President of Global Operations, effective July 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716696044/en/ Anthony Giannetti, SVP Global Operations Giannetti brings more than two decades of operations and supply chain leadership from some of the technology industry's largest OEMs, including Dell, where he managed reverse supply chain operations, and Apple and Microsoft, where he held additional operations leadership roles. His background spans production engineering, reverse logistics, and large-scale operational management, disciplines directly relevant to illumynt's work certifying and recovering value from retired AI infrastructure at scale. "Tony has spent his career on the operational side of exactly the problem we solve
Compvide ™ Announces Strategic Collaboration with OpZira ™ to Accelerate Growth and Advance the CIMED ™ Platform16.7.2026 13:47:00 EEST | Press release
Compvide, Inc., a biotechnology company pioneering functional complement intelligence through innovative diagnostics and immune-response monitoring, today announced a strategic collaboration with OpZira, Inc. to support the company’s continued growth and accelerate development of its proprietary CIMED platform. Through the collaboration, OpZira will provide comprehensive operational support across clinical, customer care, finance, manufacturing, marketing, quality, and regulatory functions,” stated Clark Tedford, Ph.D., President and CEO, OpZira, Inc. “By leveraging OpZira’s established operational infrastructure and expertise, Compvide can remain focused on advancing its scientific innovation while expanding its capabilities in complement-focused diagnostics and translational medicine.” “Partnering with an experienced organization that understands the unique needs of emerging healthcare companies is an important step for Compvide as we continue building the company,” said Sadam Yaseen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom